With trial win, AbbVie cues up Botox for another cosmetic indication kdunleavy Mon, 09/18/2023 – 13:10 More: With trial win, AbbVie cues up Botox for another cosmetic indication Source: fierce
read moreAs Lonza CEO departs, Catalent scoops up rival CDMO’s bioscience business head to lead biologics fkansteiner Mon, 09/18/2023 – 12:55 More: As Lonza CEO departs, Catalent scoops up rival CDMO's bioscience business head to lead biologics Source: fierce
read morePfizer’s ‘entrenched’ tafamidis franchise will be tough to challenge for Alnylam, BridgeBio: analysts aliu Mon, 09/18/2023 – 11:00 More: Pfizer's 'entrenched' tafamidis franchise will be tough to challenge for Alnylam, BridgeBio: analysts Source: fierce
read moreSanofi offloads 11 central nervous system meds to Pharmanovia as part of effort to slim down zbecker Mon, 09/18/2023 – 10:54 More: Sanofi offloads 11 central nervous system meds to Pharmanovia as part of effort to slim down Source: fierce
read moreLonza’s CEO reshuffle continues with the ‘abrupt’ departure of Ruffieux kdunleavy Mon, 09/18/2023 – 10:32 More: Lonza's CEO reshuffle continues with the 'abrupt' departure of Ruffieux Source: fierce
read moreThe treatment is the first oral GPCR receptor antagonist class recommended for NHS use More: Pfizer’s Vydura recommended by NICE for acute migraines Source: News
read more© 1994 - 2023 B.M. Pharmaceuticals